Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Cidara Therapeutics, Inc. has filed 798 SEC EDGAR filings since 17 Jun 2014

SEC filing history

Showing 451-475 of 798 matching filings.

Per page
25
Current page
19
S-3/A File 333-238955

S-3/A

Filing date
11 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
09 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-238955

S-3

Filing date
05 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36912

FORM 8-K

Filing date
20 May 2020
Reporting date
20 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36912

CIDARA THERAPEUTICS, INC. FORM 10-Q

Filing date
13 May 2020
Reporting date
31 Mar 2020
Next action
Verify source filing
8-K File 001-36912

FORM 8-K

Filing date
13 May 2020
Reporting date
13 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36912

DEFINITIVE ADDITIONAL MATERIALS

Filing date
29 Apr 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36912

DEFINITIVE PROXY STATEMENT

Filing date
29 Apr 2020
Reporting date
29 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36912

FORM 8-K

Filing date
14 Apr 2020
Reporting date
14 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36912

FORM 8-K

Filing date
01 Apr 2020
Reporting date
01 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Mar 2020
Reporting date
19 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Mar 2020
Reporting date
19 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Mar 2020
Reporting date
19 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Mar 2020
Reporting date
19 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Mar 2020
Reporting date
19 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Mar 2020
Reporting date
19 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
23 Mar 2020
Reporting date
24 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-236874

FORM S-8

Filing date
04 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-36912

CIDARA THERAPEUTICS, INC. 2019 FORM 10-K

Filing date
04 Mar 2020
Reporting date
31 Dec 2019
Next action
Verify source filing
8-K File 001-36912

FORM 8-K

Filing date
04 Mar 2020
Reporting date
03 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88806

SC 13G filing

Filing date
21 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88806

SC 13G filing

Filing date
21 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88806

SC 13G/A filing

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88806

AMENDMENT NO. 2 TO THE SCHEDULE 13G

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88806

SC 13G/A

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .